Description
Aflatoxin Q1 is a hydroxy metabolite of the mycotoxin aflatoxin B1. Human CYP3A4 study suggests aflatoxin Q1 is a detoxification product that is no longer mutagenic.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Aflatoxin Q1 is a hydroxy metabolite of the mycotoxin aflatoxin B1. Human CYP3A4 study suggests aflatoxin Q1 is a detoxification product that is no longer mutagenic.
| Cas No. | 52819-96-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12O7 |
| Formula Wt. | 328.27 |
| Chemical Name | (3S,6aR,9aS)-3-hydroxy-4-methoxy-2,3-dihydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene-1,11(6aH,9aH)-dione |
| IUPAC Name | (3S,6aR,9aS)-3-Hydroxy-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene-1,11-dione |
| Synonym | AFQ1 |
| Appearance | Off white powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Yourtee DM, Bean TA, Kirk-Yourtee CL. Human aflatoxin B1 metabolism: an investigation of the importance of aflatoxin Q1 as a metabolite of hepatic post-mitochondrial fraction. Toxicol Lett. 198738(3):213-24. doi: 10.1016/0378-4274(87)90002-6, PMID: 3116726
M. Yamada , K. Hatsuta , M Niikawa, et al. Detoxification of Aflatoxin B1 Contaminated Maize Using Human CYP3A4 J. Microbiol Biotechnol 2020, 28;30(8):1207-1213. doi: 10.4014/jmb.2003.03032 PMID: 32423188
Tetracycline; protein translation inhibitor, MM...
CDK2/4/6 inhibitor
Stilbenoid glucoside found in Polygonum.
Nucleoside antibiotic mixture; GlcNAc phosphotr...
β-lactam; penicillin binding protein inhibitor...
Arginine source used to increase NO production....
Azalide macrolide; protein translation inhibito...
Imidazoquinoline nucleoside analog; TLR-7/8 ago...
Vitamin D analog.
β2-adrenergic agonist.
Triazole; 14-α demethylase and aromatase inhib...
Pyrimidine analog; inhibits thymidylate synthas...
Triterpene saponin found in species of Panax.
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
Aminopeptidase inhibitor.
Type A trichothecene mycotoxin produced by Fusa...
D2/3 antagonist, hERG K+ channel blocker.
Statin; HMG-CoA reductase inhibitor.
Polyphenolic hydroxystilbene, resveratrol deri...
ERK1/2 inhibitor.